Pharmaceutical preparations containing cyclodextrin derivatives
First Claim
1. A method of producing a stablizing amorphous complex of a drug and a mixture of cyclodextrins which comprises the steps of:
- 1. Dissolving an intrinsically amorphous mixture of cyclodextrin deratives which are water soluble and capable of forming inclusion complexes with drugs in water; and
2. Solublizing lipophilic drugs into the aqueous media to form a solution and form a solublized drug/cyclodextrin complex.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention comprises pharmaceutical preparations consisting generally of a drug with a substantially low water solubility and an amorphous, water-soluble cyclodextrin-based mixtures. In these preparations a stable amorphous state can be achieved. This improves the dissolution properties of the drug and hence its absorption by the body. The required cyclodextrin-based mixtures were prepared from α-, β-, or γ-cyclodextrin which were rendered amorphous through non-selective alkylation. The alkylation agents suitable for that purposes are exemplified by propylene oxide, glycidol, iodoacetamide, chloroacetate, or 2-diethylaminoethylchloride; their reactions with cyclodextrins were performed in a manner to yield mixtures containing many components, a circumstance which effectively prevents crystallization processes within the above pharmaceutical preparation.
535 Citations
28 Claims
-
1. A method of producing a stablizing amorphous complex of a drug and a mixture of cyclodextrins which comprises the steps of:
-
1. Dissolving an intrinsically amorphous mixture of cyclodextrin deratives which are water soluble and capable of forming inclusion complexes with drugs in water; and 2. Solublizing lipophilic drugs into the aqueous media to form a solution and form a solublized drug/cyclodextrin complex. - View Dependent Claims (2, 3, 4, 5, 12)
-
- 6. A composition of matter which contains an amorphous complex of cylodextrin and a drug.
-
28. A composition of matter in solid or semi-solid form comprising at least one of testosterone, progesterone, and estradiol as an inclusion complex with poly-β
- -cylodextin and/or hydroxypropyl-β
-cyclodextrin adapted for administration by buccal route.
- -cylodextin and/or hydroxypropyl-β
Specification